Galmed Pharmaceuticals Ltd. buy Barclays PLC
Start price
25.02.26
/
50%
€6.40
Target price
25.02.27
€104.35
Performance (%)
-
Price
-
-
Summary
This prediction has just been started. It does not have a price yet.. This prediction currently runs until 25.02.27. The prediction end date can be changed by Barclays_PLC at any time.Performance without dividends (%)
| Name | 1w |
|---|---|
| Galmed Pharmaceuticals Ltd. | - |
| iShares Core DAX® | 1.232% |
| iShares Nasdaq 100 | 0.695% |
| iShares Nikkei 225® | 2.085% |
| iShares S&P 500 | 0.419% |
Comments by Barclays_PLC for this prediction
In the thread Galmed Pharmaceuticals Ltd. diskutieren
Globus Medical (GMED) had its price target raised by Barclays PLC from $118.00 to $123.00. They now have an "overweight" rating on the stock.
Ratings data for GMED provided by MarketBeat
Stopped prediction by Barclays_PLC for Galmed Pharmaceuticals Ltd.
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
10.11.25
10.11.25
€98.63
10.11.26
10.11.26
-
19.09.24
19.09.24
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€6.40
24.02.25
24.02.25
€98.39
24.02.26
24.02.26
-
25.02.26
25.02.26
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.27
08.08.24
08.08.24
€85.19
08.08.25
08.08.25
2270.37%
09.08.25
09.08.25
Galmed Pharmaceuticals Ltd.
Start price
Target price
Perf. (%)
€0.40
09.05.24
09.05.24
€78.88
09.05.25
09.05.25
1516.16%
10.05.25
10.05.25

